| Literature DB >> 23238351 |
Derek C Prosser1, Beverly Wendland.
Abstract
Eukaryotic cells use numerous endocytic pathways for nutrient uptake, protein turnover and response to the extracellular environment. While clathrin-mediated endocytosis (CME) has been extensively studied in yeast and mammalian cells, recent studies in higher eukaryotes have described multiple clathrin-independent endocytic pathways that depend upon Rho family GTPases and their effector proteins. In contrast, yeast cells have been thought to rely solely on CME. In a recent study, we used CME-defective yeast cells lacking clathrin-binding endocytic adaptor proteins in a genetic screen to identify novel factors involved in endocytosis. This approach revealed the existence of a clathrin-independent endocytic pathway involving the GTPase Rho1, which is the yeast homolog of RhoA. Further characterization of the yeast Rho1-mediated endocytic pathway suggested that the Rho1 pathway requires additional proteins that appear to play conserved roles in RhoA-dependent, clathrin-independent endocytic pathways in mammalian cells. Here, we discuss the parallels between the yeast Rho1-dependent and mammalian RhoA-dependent endocytic pathways, as well as the applications of yeast as a model for studying clathrin-independent endocytosis in higher eukaryotes.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23238351 PMCID: PMC3520887 DOI: 10.4161/sgtp.21631
Source DB: PubMed Journal: Small GTPases ISSN: 2154-1248

Figure 1. Specificity for Rho1 as a high-copy suppressor of endocytic defects in 4Δ+ENTH1 cells. (A) Wild-type (WT), 4Δ+Ent1 and 4Δ+ENTH1 cells expressing Ste3-GFP were transformed with empty vector or high-copy plasmids containing RHO1, RHO2, RHO3, RHO4, RHO5, or CDC42 to overexpress individual Rho GTPases as indicated. Cells were imaged by fluorescence microscopy to visualize Ste3-GFP, the a-factor mating pheromone receptor that is constitutively internalized and targeted to the vacuole in WT cells, but is partially retained at the plasma membrane when endocytosis is disrupted. (B) WT, 4Δ+Ent1 and 4Δ+ENTH1 cells expressing Ste3-pHluorin were transformed as described in panel A, and Ste3-pHluorin fluorescence intensity was quantified, with intensity values corrected for cell size. We recently developed a method for quantification of endocytosis in yeast cells using super-ecliptic pHluorin as a pH-sensitive GFP variant that becomes quenched in the acidic vacuole, allowing measurement of only fluorescently-tagged cargos that are outside of the vacuole. While cells with intact CME (WT and 4Δ+Ent1) are dim because Ste3-pHluorin is mainly localized in the vacuole, cells with defective CME (4Δ+ENTH1) are comparatively bright because a significant population of Ste3 is retained at the cell surface. Values are presented as mean ± SEM from a minimum of 30 cells per condition, and statistical significance was assessed by one-way ANOVA with Neuman-Keuls post hoc analysis (*** p < 0.001 compared with 4Δ+ENTH1 + vector). All strains used in this analysis were described previously.

Figure 2. Model of clathrin-mediated and Rho1-mediated endocytic pathways in yeast. Although many proteins contribute to CME which occurs at cortical actin patches (left), the model is simplified to display proteins that are critical for functional CME but that we have found are not required for endocytosis in the presence of high-copy components of the Rho1 pathway. CME components that are not required for Rho1-mediated endocytosis include coat proteins (clathrin and the adaptors Ent1, Ent2, Yap1801 and Yap1802), the Arp2/3-activating WASp homolog Las17, and the branched actin-bundling proteins Sac6/fimbrin and Scp1/transgelin. Components of the Rho1 pathway (right) do not localize to cortical actin patches, and are thought to act independently of the CME machinery. The Rho1 pathway ultimately promotes extension of tropomyosin-stabilized unbranched actin filaments through the activity of the formin Bni1, although how membrane deformation is achieved at sites of Rho1-mediated endocytosis is currently unclear.
Table 1. Comparison of shared components of the known Rho1/RhoA endocytic pathways
| Yeast Rho1 pathway | RhoA-dependent phagocytosis | Mammalian RhoA-dependent CIE | |
|---|---|---|---|
| GTPase(s) involved | Rho1 | RhoA (other phagocytic pathways use Rac1 and/or Cdc42) | RhoA |
| GEF(s) involved | Rom1, Rom2 | various, including Vav1 and Vav3 | ? |
| formin requirement | Bni1 (diaphanous-related formin) | mDia1, mDia2 (diaphanous-related formins) | ? |
| dynamin involvement | Vps1? ( | Dynamin-232 | Dynamin-1 |
| integrin involvement | Mid2? (integrin-like, with a heavily glycosylated ectodomain and a short cytoplasmic domain that signals to the cell interior) | β1 subunit (α4β1 and α5β1 integrins), β2 subunit (αMβ2) | ? |
| polarity proteins | polarisome complex (Spa2, Bud6 and Bni1 subunits) | ? | ? |
| cargo/receptor | ? | various receptors, including integrins | interleukin 2 receptor (IL2R) |